Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase II Randomized Controlled Double Blind Trial of 81mg Aspirin Daily vs. 1000 mg Aspirin Daily vs. Placebo as Adjunctive Therapy in HIV Negative Adults With Tuberculous Meningitis

NCT02237365 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit, Vietnam as lead sponsor.

NCT NCT02237365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase II Randomized Controlled Double Blind Trial of 81mg Aspirin Daily vs. 1000 mg Aspirin Daily vs. Placebo as Adjunctive Therapy in HIV Negative Adults With Tuberculous Meningitis
Lead sponsor
Oxford University Clinical Research Unit, Vietnam
Phase
Phase 2
Overall status
Completed
Start date
October 17, 2014
Completion date
December 22, 2016
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculous meningitis